In the survival analysis, Cf-mtDNA levels demonstrated no significant association with key clinical outcomes in patients with ALS, including death, tracheostomy-free survival, and the use of supportive interventions, such as NIV, PEG, and IV. The gene discussed is CFTR; the disease is amyotrophic lateral sclerosis.